Cure SMA Basic Research Grant
Funds novel research on spinal muscular atrophy biology and drug target identification worldwide.
Cure SMA is a US-based 501(c)(3) patient advocacy foundation (EIN: 36-3320440, headquartered in Schaumburg, Illinois) that has invested over $82 million in spinal muscular atrophy research since 1984, including more than $15 million across 128 basic research grants. Its annual Basic Research Grant programme funds novel scientific investigation into SMA biology, with the explicit goal of identifyin…
Novel research on SMA biology: disease pathology, drug target identification, therapeutic strategies, reagents/tools for drug development and clinical trials.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline